Chemoinformaics analysis of 2-Furoic acid, (3-cyanopropyl)dimethylsilyl ester
| Molecular Weight | 237.331 | nRot | 5 |
| Heavy Atom Molecular Weight | 222.211 | nRig | 7 |
| Exact Molecular Weight | 237.082 | nRing | 1 |
| Solubility: LogS | -3.606 | nHRing | 1 |
| Solubility: LogP | 2.291 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 5 |
| nHA | 4 | APOL | 37.4079 |
| nHD | 0 | BPOL | 35.3981 |
| QED | 0.583 |
| Synth | 2.967 |
| Natural Product Likeliness | -0.758 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.05 |
| Pgp-sub | 0.004 |
| HIA | 0.279 |
| CACO-2 | -4.664 |
| MDCK | 0.0000906 |
| BBB | 0.06 |
| PPB | 0.992262 |
| VDSS | 2.354 |
| FU | 0.00884578 |
| CYP1A2-inh | 0.751 |
| CYP1A2-sub | 0.667 |
| CYP2c19-inh | 0.05 |
| CYP2c19-sub | 0.051 |
| CYP2c9-inh | 0.179 |
| CYP2c9-sub | 0.609 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.066 |
| CYP3a4-inh | 0.022 |
| CYP3a4-sub | 0.099 |
| CL | 6.255 |
| T12 | 0.909 |
| hERG | 0.009 |
| Ames | 0.031 |
| ROA | 0.716 |
| SkinSen | 0.121 |
| Carcinogencity | 0.768 |
| EI | 0.988 |
| Respiratory | 0.971 |
| NR-Aromatase | 0.024 |
| Antiviral | No |
| Prediction | 0.641365 |